Webinars

SCLC's webinar series is integral to the technical assistance provided by the SCLC. Nationally recognized smoking cessation experts offer the latest information related to smoking cessation (including effective interventions) for the general and the behavioral health populations.

The Goals of SCLC’s Webinar Series:

  • Provide training and technical assistance to raise awareness of the many benefits smoking cessation efforts and to increase understanding of effective smoking cessation strategies.
  • Implement or enhance existing tobacco cessation services using evidence-based practices.
  • Ensure that consumers and staff have access to smoking cessation services and support to promote health and wellness.
  • Establish partnerships between behavioral health and nicotine cessation organizations to increase available tobacco cessation resources in communities. 

SCLC has over 90 webinars covering the latest topics on tobacco addiction and recovery

Click here for information on the Recorded Webinar Collections with FREE CME/CEUs

Current Webinars

A Comprehensive Look at the Health Effects of Nicotine

Speakers

Neal L. Benowitz, MD

Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences, University of California, San Francisco

Neal L. Benowitz, MD, is Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences at the University of California, San Francisco (UCSF). He was Chief of the Division of Clinical Pharmacology and Experimental Therapeutics at UCSF for 35 years. He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974. His research interests have focused primarily on the human pharmacology and toxicology of nicotine. He has published more than 700 research papers. Dr Benowitz maintains an active clinical practice in cardiovascular medicine and medical toxicology.

Dr Benowitz was a scientific editor of the 1988 United States Surgeon General’s Report on Smoking and Health: Nicotine Addiction; a scientific editor of the 2001 NCI Monograph 13 Report on Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine; and served as section editor for the 2010 Surgeon General’s Report on How Tobacco Smoke Causes Disease. He, has served as a member of the National Institutes of Health Pharmacology Study Section and the FDA Nonprescription Drug and Tobacco Products Science Advisory Committees. He has served as President of the American Society for Clinical Pharmacology and Therapeutics and as President of the Society for Research on Nicotine and Tobacco. Dr Benowitz has received the Ove Ferno, Alton Ochsner, and Rawls-Palmer Progress in Medicine awards, and the Oscar B. Hunter Memorial Award in Therapeutics for his research on nicotine, tobacco, and health, and was the 2002 UCSF Annual Distinguished Clinical Research Lecturer.

Webinar Objectives

  1. Describe major safety concerns for nicotine, independent of combusted tobacco
  2. Identify nicotine levels and pharmacokinetics from various tobacco products, and implications for addiction and disease risk
  3. Explain potential effects of nicotine on the developing fetal and adolescent brains
  4. Describe cardiovascular and respiratory concerns from nicotine with use of electronic nicotine delivery devices.